biote Corp. BTMD

BTMD Company Overview

biote Corp. is a U.S.-based healthcare company focused on preventive health care and hormone optimization therapies, primarily through bioidentical hormone replacement therapy (BHRT). The company operates in the wellness and preventive medicine sectors and provides a practice-building platform for physicians and clinicians that includes hormone therapy training, diagnostic support, nutraceutical supplements, and patient management tools. biote’s primary revenue drivers include sales of hormone optimization products, dietary supplements, and recurring procedure-related revenue generated through its network of certified practitioners.

The company’s business model centers on enabling medical providers to offer personalized hormone therapy solutions, primarily using subcutaneous pellet therapy designed to deliver hormones consistently over time. biote serves patients seeking treatment for age-related hormonal imbalance and wellness-related conditions, with a significant concentration in the U.S. cash-pay health care market. Originally established as a privately held company, biote later became publicly traded through a business combination with a special purpose acquisition company (SPAC), resulting in its listing on Nasdaq under the ticker BTMD. Its strategic positioning is tied to its practitioner network, recurring patient relationships, and integrated training-and-product ecosystem.